Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients: Multicenter Interventional Study

NCT04474340 is registered in ClinicalTrials.gov with Ministry of Health, Kuwait as lead sponsor.

NCT NCT04474340
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04474340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients: Multicenter Interventional Study
Lead sponsor
Ministry of Health, Kuwait
Phase
Phase 1
Overall status
Unknown status
Start date
May 21, 2020
Completion date
December 30, 2020
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

moderate covid-19 pneumonia, severe covid-19 pneumonia, pneumonia, viral